Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

NEW YORK, Jan. 17, 2012 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

http://www.reportlinker.com/p0761161/Genetic-Testing-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Summary GlobalData’s new report, “Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Genetic Testing market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within three market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations. The report also provides company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope – Market size data for Genetic Testing market categories – Inborn Gene or Chromosome Alterations, Other Genetic Tests and Acquired Gene or Chromosome Alterations.

– Annualized market revenues ($m) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.

– 2010 company shares and distribution shares data for the overall Genetic Testing market in each of the aforementioned countries.

– Global corporate-level profiles of key companies operating within the Genetic Testing market in BRICS.

– Key players covered include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthcare, Qiagen N.V., Bio-Rad Laboratories, Inc. and Gen-Probe Incorporated.
Reasons to buy – Develop business strategies by identifying the key market categories and segments poised for strong growth.

– Develop market-entry and market expansion strategies.

– Design competition strategies by identifying who-stands-where in the Genetic Testing competitive landscape in BRICS.

– Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 82 Introduction 102.1 What is This Report About? 103 Genetic Testing in BRICS 113.1 Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 113.2 Genetic Testing, BRICS, Company share (2009-2010) 174 Genetic Testing In Brazil 194.1 Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 194.2 Inborn Gene or Chromosome Alterations In Brazil 254.2.1 Inborn Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017) 254.3 Other Genetic Tests In Brazil 274.3.1 Other Genetic Tests, Brazil, Overall Revenue (2003-2017) 274.4 Acquired Gene or Chromosome Alterations In Brazil 294.4.1 Acquired Gene or Chromosome Alterations, Brazil, Overall Revenue (2003-2017) 294.5 Genetic Testing, Brazil, Distribution Share (2009-2010) 314.6 Genetic Testing, Brazil, Company Share (2009-2010) 325 Genetic Testing In Russian Federation 345.1 Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 345.2 Inborn Gene or Chromosome Alterations in Russian Federation 405.2.1 Inborn Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017) 405.3 Other Genetic Tests In Russian Federation 425.3.1 Other Genetic Tests, Russian Federation, Overall Revenue (2003-2017) 425.4 Acquired Gene or Chromosome Alterations In Russian Federation 445.4.1 Acquired Gene or Chromosome Alterations, Russian Federation, Overall Revenue (2003-2017) 445.5 Genetic Testing, Russian Federation, Distribution Share (2009-2010) 475.6 Genetic Testing, Russian Federation, Company Share (2009-2010) 486 Genetic Testing In India 506.1 Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 506.2 Inborn Gene or Chromosome Alterations in India 566.2.1 Inborn Gene or Chromosome Alterations, India, Overall Revenue (2003-2017) 566.3 Other Genetic Tests In India 586.3.1 Other Genetic Tests, India, Overall Revenue (2003-2017) 586.4 Acquired Gene or Chromosome Alterations In India 606.4.1 Acquired Gene or Chromosome Alterations, India, Overall Revenue (2003-2017) 606.5 Genetic Testing, India, Distribution Share (2009-2010) 626.6 Genetic Testing, India, Company Share (2009-2010) 637 Genetic Testing In China 657.1 Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 657.2 Inborn Gene or Chromosome Alterations In China 717.2.1 Inborn Gene or Chromosome Alterations, China, Overall Revenue (2003-2017) 717.3 Other Genetic Tests In China 737.3.1 Other Genetic Tests, China, Overall Revenue (2003-2017) 737.4 Acquired Gene or Chromosome Alterations In China 757.4.1 Acquired Gene or Chromosome Alterations, China, Overall Revenue (2003-2017) 757.5 Genetic Testing, China, Distribution Share (2009-2010) 777.6 Genetic Testing, China, Company Share (2009-2010) 788 Genetic Testing In South Africa 808.1 Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 808.2 Inborn Gene or Chromosome Alterations In South Africa 868.2.1 Inborn Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017) 868.3 Other Genetic Tests In South Africa 888.3.1 Other Genetic Tests, South Africa, Overall Revenue (2003-2017) 888.4 Acquired Gene or Chromosome Alterations In South Africa 908.4.1 Acquired Gene or Chromosome Alterations, South Africa, Overall Revenue (2003-2017) 908.5 Genetic Testing, South Africa, Distribution Share (2009-2010) 928.6 Genetic Testing, South Africa, Company Share (2009-2010) 939 Overview of Key Companies in BRICS Genetic Testing Market 959.1 F. Hoffmann-La Roche Ltd. 959.1.1 Company Overview 959.1.2 Share in the BRICS Genetic Testing Market 969.2 Abbott Laboratories 979.2.1 Company Overview 979.2.2 Share in the BRICS Genetic Testing Market 989.3 Siemens Healthcare 999.3.1 Company Overview 999.3.2 Share in the BRICS Genetic Testing Market 1009.4 Qiagen N.V. 1019.4.1 Company Overview 1019.4.2 Share in the BRICS Genetic Testing Market 1029.5 Bio-Rad Laboratories, Inc. 1039.5.1 Company Overview 1039.5.2 Share in the BRICS Genetic Testing Market 1049.6 Gen-Probe Incorporated 1059.6.1 Company Overview 1059.6.2 Share in the BRICS Genetic Testing Market 10610 Appendix 10710.1 Definitions of Markets Covered in the Report 10810.1.1 Genetic Testing 10810.2 Research Methodology 10910.3 Secondary Research 10910.4 Primary Research 11010.5 Models 11010.6 Forecasts 11110.7 Expert Panels 11110.8 GlobalData Consulting 11110.9 Currency Conversion 11210.10 Contact Us 11210.11 Disclaimer 112

List of Tables

Table 1: Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 12Table 2: Genetic Testing, BRICS, Overall Revenue ($m), Historic, 2003-2010 14Table 3: Genetic Testing, BRICS, Overall Revenue ($m), Forecast, 2010-2017 16Table 4: Genetic Testing, BRICS, Company share by Revenue ($m), USD Actual, 2009-2010 18Table 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 20Table 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22Table 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24Table 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 25Table 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 26Table 10: Other Genetic Tests, Brazil, Revenue ($m), Historic, 2003-2010 27Table 11: Other Genetic Tests, Brazil, Revenue ($m), Forecast, 2010-2017 28Table 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 29Table 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 30Table 14: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31Table 15: Genetic Testing, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 33Table 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 35Table 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 37Table 18: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 39Table 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 40Table 20: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 41Table 21: Other Genetic Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 42Table 22: Other Genetic Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 43Table 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 45Table 24: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 46Table 25: Genetic Testing, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 47Table 26: Genetic Testing, Russian Federation, Company share by Revenue ($m), USD Actual, 2009-2010 49Table 27: Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 51Table 28: Genetic Testing, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 53Table 29: Genetic Testing, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 55Table 30: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 56Table 31: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 57Table 32: Other Genetic Tests, India, Revenue ($m), Historic, 2003-2010 58Table 33: Other Genetic Tests, India, Revenue ($m), Forecast, 2010-2017 59Table 34: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 60Table 35: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 61Table 36: Genetic Testing, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 62Table 37: Genetic Testing, India, Company share by Revenue ($m), USD Actual, 2009-2010 64Table 38: Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 66Table 39: Genetic Testing, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 68Table 40: Genetic Testing, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 70Table 41: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 71Table 42: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 72Table 43: Other Genetic Tests, China, Revenue ($m), Historic, 2003-2010 73Table 44: Other Genetic Tests, China, Revenue ($m), Forecast, 2010-2017 74Table 45: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 75Table 46: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 76Table 47: Genetic Testing, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 77Table 48: Genetic Testing, China, Company share by Revenue ($m), USD Actual, 2009-2010 79Table 49: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 81Table 50: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 83Table 51: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 85Table 52: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 86Table 53: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 87Table 54: Other Genetic Tests, South Africa, Revenue ($m), Historic, 2003-2010 88Table 55: Other Genetic Tests, South Africa, Revenue ($m), Forecast, 2010-2017 89Table 56: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 90Table 57: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 91Table 58: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 92Table 59: Genetic Testing, South Africa, Company share by Revenue ($m), USD Actual, 2009-2010 94Table 60: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Genetic Testing Market, 2010 96Table 61: Abbott Laboratories, Revenue ($m), BRICS Genetic Testing Market, 2010 98Table 62: Siemens Healthcare, Revenue ($m), BRICS Genetic Testing Market, 2010 100Table 63: Qiagen N.V., Revenue ($m), BRICS Genetic Testing Market, 2010 102Table 64: Bio-Rad Laboratories, Inc., Revenue ($m), BRICS Genetic Testing Market, 2010 104Table 65: Gen-Probe Incorporated, Revenue ($m), BRICS Genetic Testing Market, 2010 106Table 66: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 112

List of Figures

Figure 1: Genetic Testing, BRICS, Overall Revenue ($m), 2003-2017 11Figure 2: Genetic Testing, BRICS, Overall Revenue ($m), Historic, 2003-2010 13Figure 3: Genetic Testing, BRICS, Overall Revenue ($m), Forecast, 2010-2017 15Figure 4: Genetic Testing, BRICS, Company share (%), 2010 17Figure 5: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 19Figure 6: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 21Figure 7: Genetic Testing, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 23Figure 8: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 25Figure 9: Inborn Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 26Figure 10: Other Genetic Tests, Brazil, Revenue ($m), Historic, 2003-2010 27Figure 11: Other Genetic Tests, Brazil, Revenue ($m), Forecast, 2010-2017 28Figure 12: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Historic, 2003-2010 29Figure 13: Acquired Gene or Chromosome Alterations, Brazil, Revenue ($m), Forecast, 2010-2017 30Figure 14: Genetic Testing, Brazil, Company share (%), 2010 32Figure 15: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 34Figure 16: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36Figure 17: Genetic Testing, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 38Figure 18: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 40Figure 19: Inborn Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 41Figure 20: Other Genetic Tests, Russian Federation, Revenue ($m), Historic, 2003-2010 42Figure 21: Other Genetic Tests, Russian Federation, Revenue ($m), Forecast, 2010-2017 43Figure 22: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Historic, 2003-2010 44Figure 23: Acquired Gene or Chromosome Alterations, Russian Federation, Revenue ($m), Forecast, 2010-2017 46Figure 24: Genetic Testing, Russian Federation, Company share (%), 2010 48Figure 25: Genetic Testing, India, Overall Revenue ($m), USD Actual, 2003-2017 50Figure 26: Genetic Testing, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 52Figure 27: Genetic Testing, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 54Figure 28: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 56Figure 29: Inborn Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 57Figure 30: Other Genetic Tests, India, Revenue ($m), Historic, 2003-2010 58Figure 31: Other Genetic Tests, India, Revenue ($m), Forecast, 2010-2017 59Figure 32: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Historic, 2003-2010 60Figure 33: Acquired Gene or Chromosome Alterations, India, Revenue ($m), Forecast, 2010-2017 61Figure 34: Genetic Testing, India, Company share (%), 2010 63Figure 35: Genetic Testing, China, Overall Revenue ($m), USD Actual, 2003-2017 65Figure 36: Genetic Testing, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 67Figure 37: Genetic Testing, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 69Figure 38: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 71Figure 39: Inborn Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 72Figure 40: Other Genetic Tests, China, Revenue ($m), Historic, 2003-2010 73Figure 41: Other Genetic Tests, China, Revenue ($m), Forecast, 2010-2017 74Figure 42: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Historic, 2003-2010 75Figure 43: Acquired Gene or Chromosome Alterations, China, Revenue ($m), Forecast, 2010-2017 76Figure 44: Genetic Testing, China, Company share (%), 2010 78Figure 45: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 80Figure 46: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 82Figure 47: Genetic Testing, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 84Figure 48: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 86Figure 49: Inborn Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 87Figure 50: Other Genetic Tests, South Africa, Revenue ($m), Historic, 2003-2010 88Figure 51: Other Genetic Tests, South Africa, Revenue ($m), Forecast, 2010-2017 89Figure 52: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Historic, 2003-2010 90Figure 53: Acquired Gene or Chromosome Alterations, South Africa, Revenue ($m), Forecast, 2010-2017 91Figure 54: Genetic Testing, South Africa, Company share (%), 2010 93Figure 55: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Genetic Testing Market, 2010 96Figure 56: Abbott Laboratories, Company Share (%), BRICS Genetic Testing Market, 2010 98Figure 57: Siemens Healthcare, Company Share (%), BRICS Genetic Testing Market, 2010 100Figure 58: Qiagen N.V., Company Share (%), BRICS Genetic Testing Market, 2010 102Figure 59: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Genetic Testing Market, 2010 104Figure 60: Gen-Probe Incorporated, Company Share (%), BRICS Genetic Testing Market, 2010 106

Companies mentioned

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

Siemens Healthcare

Qiagen N.V.

Bio-Rad Laboratories, Inc.

Gen-Probe Incorporated
To order this report:Genomics Industry: Genetic Testing Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

More
Market Research Report

Check our
Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Back to top

RELATED LINKS
http://www.reportlinker.com

Share
This entry was posted in South Africa News and tagged , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply